What do we know about the antibody responses to SARS-CoV-2?

被引:27
|
作者
Alejandro Lagunas-Rangel, Francisco [1 ]
Chavez-Valencia, Venice [2 ]
机构
[1] Inst Politecn Nacl CINVESTAV, Dept Genet & Mol Biol, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico
[2] Hosp Gen Reg Hosp 1, Inst Mexicano Seguro Social, Dept Nephrol, Morelia, Michoacan, Mexico
关键词
COVID-19; Humoral response; Seroconversion; Convalescent plasma; NEUTRALIZING ANTIBODIES;
D O I
10.1016/j.imbio.2021.152054
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide causing a pandemic with millions of infected people and deaths. Currently, the scientific community is working hard to develop a specific vaccine or treatment. However, since antibody production is an important part of the adaptive immune response, to develop vaccines and therapies, we must understand the antibody response to SARS-CoV-2 infection. In this work, we summarize the most important findings of antibody-mediated immunity against SARS-CoV-2 and highlight its role in the efficient use of plasma from convalescent patients and the direct application of antibodies as treatment.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] What do we know about pathological mechanism and pattern of lung injury related to SARS-CoV-2 Omicron variant?
    Roberto Scendoni
    Mariano Cingolani
    [J]. Diagnostic Pathology, 18
  • [32] What are protective antibody responses to pandemic SARS-CoV-2?
    Henderson, Jeffrey P.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (12): : 6232 - 6234
  • [33] What do we know about pathological mechanism and pattern of lung injury related to SARS-CoV-2 Omicron variant?
    Scendoni, Roberto
    Cingolani, Mariano
    [J]. DIAGNOSTIC PATHOLOGY, 2023, 18 (01)
  • [34] SARS-CoV-2 and the pancreas: What do we know about acute pancreatitis in COVID-19 positive patients?
    Brisinda, Giuseppe
    Chiarello, Maria Michela
    Tropeano, Giuseppe
    Altieri, Gaia
    Puccioni, Caterina
    Fransvea, Pietro
    Bianchi, Valentina
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (36) : 5240 - 5249
  • [35] COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic?
    Kotfis, Katarzyna
    Roberson, Shawniqua Williams
    Wilson, Jo Ellen
    Pun, Brenda T.
    Ely, E. Wesley
    Jezowska, Ilona
    Jezierska, Maja
    Dabrowski, Wojciech
    [J]. ANAESTHESIOLOGY INTENSIVE THERAPY, 2020, 52 (02) : 132 - 138
  • [36] SARS-CoV-2 and the pancreas: What do we know about acute pancreatitis in COVID-19 positive patients?
    Giuseppe Brisinda
    Maria Michela Chiarello
    Giuseppe Tropeano
    Gaia Altieri
    Caterina Puccioni
    Pietro Fransvea
    Valentina Bianchi
    [J]. World Journal of Gastroenterology, 2022, 28 (36) : 5240 - 5249
  • [37] SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
    Paul Lingor
    Antonia F. Demleitner
    Andreas W. Wolff
    Emily Feneberg
    [J]. Journal of Neural Transmission, 2022, 129 : 1155 - 1167
  • [38] Omicron SARS-CoV-2 variant: What we know and what we don't
    Ferre, Valentine Marie
    Peiffer-Smadja, Nathan
    Visseaux, Benoit
    Descamps, Diane
    Ghosn, Jade
    Charpentier, Charlotte
    [J]. ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2022, 41 (01)
  • [39] SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't
    Lingor, Paul
    Demleitner, Antonia F.
    Wolff, Andreas W.
    Feneberg, Emily
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (09) : 1155 - 1167
  • [40] A critical review on SARS-CoV-2 infectivity in water and wastewater. What do we know?
    Giacobbo, Alexandre
    Rodrigues, Marco Antonio Siqueira
    Ferreira, Jane Zoppas
    Bernardes, Andrea Moura
    de Pinho, Maria Norberta
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 774